Publikationsverzeichnis_schrader

Dr. med. Henning Schrader
Publikationsverzeichnis
Erst- oder Letztautorschaften

• Schrader H, Wiese M, Ellrichmann M, Belyaev O, Uhl W, Tannapfel A, Schmidt WE, Meier JJ. Diagnostic Value of Quantitative EUS Elastography for Malignant Pancreatic Tumors: Relationship with Pancreatic Fibrosis. Ultraschall Med. 2011 May 31. • Schrader H, Menge BA, Zeidler C, Ritter PR, Tannapfel A, Uhl W, Schmidt WE, Meier JJ. Determinants of glucose control in patients with chronic pancreatitis__ _ Diabetologia 2010
un;53(6):1062-9. Menge BA, Schrader H*, Ritter PR, Ellrichmann M, Uhl W, Schmidt WE,
Meier JJ. Selective amino acid deficiency in patients with impaired glucose tolerance and type
2 diabetes. Regul Pept. 2010 Feb 25;160(1-3):75-80.
• Schrader H, Menge BA, Breuer TGK, Ritter PR, Uhl W, Holst JJ, Schmidt WE, Meier JJ. Impaired glucose-induced glucagon suppression after partial pancreatectomy. J Clin Endocrinol Metab. 2009 Aug;94(8):2857-63. Meier JJ, Menge BA, Breuer TGK, Seelig M, Tannapfel A, Uhl W, Schmidt WE, Schrader H. Functional assessment of pancreatic beta-cell area in humans. Diabetes 2009 Jul;58(7):1595-603 • Schrader H, Menge BA, Belyaev O, Uhl W, Schmidt WE, Meier JJ. Amino Acid Malnutrition in Patients With Chronic Pancreatitis and Pancreatic Carcinoma. Pancreas 2009 May;38(4):416-21. Schrader H, Menge BA, Schneider S, Belyaev O, Tannapfel A, Uhl W, Schmidt WE, Meier JJ. Reduced Pancreatic Volume and beta-Cell Area in Patients With Chronic Pancreatitis. Gastroenterology 2009 Feb;136(2):513-22. • Menge BA, Schrader H*, Breuer TG, Dabrowski Y, Uhl W, Schmidt WE, Meier JJ. Metabolic consequences of a 50% partial pancreatectomy in humans. Diabetologia 2009 Feb;52(2):306-17. • Schrader H. Endoskopie zur Früherkennung und Therapie kolorektaler Neoplasien. Der • Schrader H, Schmitz F. Endosonographische Elastographie. Neue Entscheidungshilfe zwischen gut- und bösartigem Gewebe oder einfach nur schön bunt? Der Gastroenterologe 2007;2(1):44-47. • Schrader H, Schmidt WE. [Prognostic significance of cyclooxygenase 2 expression in adenocarcinoma of the esophagus] Z Gastroenterol 2003;41(7):679-81.
Koautorenschaften

• Herzog T, Belyaev O, Hessam S, Suelberg D, Janot M, Schrader H, Schmidt WE, Anders A, Uhl W, Mueller CA. Bacteribilia with resistant microorganisms after preoperative biliary drainage - the influence of bacteria on postoperative outcome. Scand J Gastroenterol. 2012 Jul;47(7):827-35. Epub 2012 Apr 17 • Meier JJ, Breuer TG, Bonadonna RC, Tannapfel A, Uhl W, Schmidt WE, Schrader H, Menge BA. Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. Diabetologia. 2012 May;55(5):1346-54 • Pennartz C, Schrader H, Ritter PR, Tannapfel A, Schmidt WE, Meier JJ. [Unclear hepatopathy in a patient with atrial fibrillation]. Internist (Berl). 2012 Jan;53(1):88-92. doi: 10.1007/s00108-011-2908-2. • Ellrichmann M, Ritter PR, Schrader H, Schmidt WE, Meier JJ, Schmitz F. Gastrin stimulates the VEGF-A promotor in a human colon cancer cell line. Regul Pept. 2010 Dec 10;165(2-3):146-50. Epub 2010 Jun 28 • Ellrichmann M, Vollmer K, Schrader H, Banasch M, Schmidt WE, Meier JJ. Sustained virological response during exenatide treatment in a patient with hepatitis C and nonalcoholic steatohepatitis. Am J Gastroenterol. 2009 Dec;104(12):3112-4. • Herzog T, Belyaev O, Muller CA, Mittelkotter U, Seelig MH, Weyhe D, Felderbauer P, Schlottmann R, Schrader H, Schmidt WE, Uhl W. Bacteribilia After Preoperative Bile Duct Stenting: A Prospective Study. J Clin Gastroenterol. 2009 May-Jun;43(5):457-62. • Otte JM, Neumann HM, Brand S, Schrader H, Schmidt WE, Schmitz F. Expression of beta- defensin 4 is increased in human gastritis. Eur J Clin Invest. 2009 Feb;39(2):126-38. • Huang H, Ansorge N, Schrader H, Banasch M, Yu HG, Schmidt WE, Höcker M, Schmitz F. The CCK-2/gastrin splice variant receptor retaining intron 4 transactivates the COX-2 promoter in vitro. Regul Pept 2007;144(1-3):34-42. • Ellrichmann M, Ritter PR, Otte JM, Schrader H, Banasch M, Brunke G, Herzig KH, Seebeck J, Schmidt WE, Schmitz F. Orlistat reduces gallbladder emptying by inhibition of CCK release in response to a test meal. Regul Pept 2007;139(1-3):136-40. • Banasch M, Bulut K, Hagemann D, Schrader H, Holst JJ, Schmidt WE, Meier JJ. Glucagon- like peptide 2 inhibits ghrelin secretion in humans. Regul Pept 2006;137(3):173-8. • Yu HG, Schrader H, Otte JM, Schmidt WE, Schmitz F. Rapid tyrosine phosphorylation of focal adhesion kinase, paxillin, and p130Cas by gastrin in human colon cancer cells. Biochem Pharmacol 2004;67(1):135-46. • Yu HG, Zhong X, Yang YN, Luo HS, Yu JP, Meier JJ, Schrader H, Bastian A, Schmidt WE, Schmitz F. Increased expression of nuclear factor-kappaB/RelA is correlated with tumor angiogenesis in human colorectal cancer. Int J Colorectal Dis 2004;19(1):18-22. • Yu HG, Yu LL, Yang Y, Luo HS, Yu JP, Meier JJ, Schrader H, Bastian A, Schmidt WE, Schmitz F. Increased expression of RelA/nuclear factor-kappa B protein correlates with Colorectal tumorigenesis. Oncology 2003;65(1):37-45. • Yu HG, Huang JA, Yang YN, Luo HS, Yu JP, Meier JJ, Schrader H, Bastian A, Schmidt WE, Schmitz F. Inhibition of cytosolic phospholipase A2 mRNA expression: a novel mechanism for acetylsalicylic acidmediated growth inhibition and apoptosis in colon cancer cells. Regul Pept 2003;114(2-3):101-7. • Yu HG, Li JY, Yang YN, Luo HS, Yu JP, Meier JJ, Schrader H, Bastian A, Schmidt WE, Schmitz F. Increased abundance of cyclooxygenase-2 correlates with vascular endothelial growth factor-A abundance and tumor angiogenesis in gastric cancer. Cancer Lett 2003;195(1):43-51. • Yu HG, Huang JA, Yang YN, Huang H, Luo HS, Yu JP, Meier JJ, Schrader H, Bastian A, Schmidt WE, Schmitz F. The effects of acetylsalicylic acid on proliferation, apoptosis, and invasion of cyclooxygenase-2 negative colon cancer cells. Eur J Clin Invest 2002;32(11):838-46. • Yu HG, Shun LB, Luo HS, Huang H, Yu BP, Yu JP, Meier JJ, Schrader H, Bastian A, Schmitz F, Schmidt WE. Deletion of the FHIT gene in human colorectal cancer is independent of high-risk HPV infection. Int J Colorectal Dis 2002;17(6):396-401. • Hinrichsen H, Leimenstoll G, Stegen G, Schrader H, Fölsch UR, Schmidt WE; PHV Study Group. Prevalence and risk factors of hepatitis C virus infection in haemodialysis Patients: a multicentre study in 2796 patients. Gut 2002;51(3):429-33. • Hinrichsen H, Leimenstoll G, Stegen G, Schrader H, Fölsch UR, Schmidt WE; PHV Study Group. Prevalence of and risk factors for hepatitis G (HGV) infection in haemodialysis patients: a multicentre study. Nephrol Dial Transplant 2002;17(2):271-5. • Schmitz F, Göke MN, Otte JM, Schrader H, Reimann B, Kruse ML, Siegel EG, Peters J, Herzig KH, Fölsch UR, Schmidt WE. Cellular expression of CCK-A and CCK-B/gastrin receptors in human gastric mucosa. Regul Pept 2001;102(2-3):101-10. • Schmitz F, Schrader H, Otte J, Schmitz H, Stüber E, Herzig K, Schmidt WE. Identification of CCK-B/gastrin receptor splice variants in human peripheral blood mononuclear cells. Regul Pept 2001;101(1-3):25-33. Erratum in: Regul Pept 2001;102(2-3):165.

Source: http://www.sana-gerresheim.de/uploads/tx_templavoila/Publikationsverzeichnis_Schrader.pdf